JPS6466129A - Medicine for preventing and treating complication of diabetes - Google Patents

Medicine for preventing and treating complication of diabetes

Info

Publication number
JPS6466129A
JPS6466129A JP63201000A JP20100088A JPS6466129A JP S6466129 A JPS6466129 A JP S6466129A JP 63201000 A JP63201000 A JP 63201000A JP 20100088 A JP20100088 A JP 20100088A JP S6466129 A JPS6466129 A JP S6466129A
Authority
JP
Japan
Prior art keywords
insulin
preparation
formula
implant
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63201000A
Other languages
English (en)
Inventor
Haisuman Robii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS6466129A publication Critical patent/JPS6466129A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP63201000A 1987-08-14 1988-08-11 Medicine for preventing and treating complication of diabetes Pending JPS6466129A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701912 1987-08-14

Publications (1)

Publication Number Publication Date
JPS6466129A true JPS6466129A (en) 1989-03-13

Family

ID=19850453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63201000A Pending JPS6466129A (en) 1987-08-14 1988-08-11 Medicine for preventing and treating complication of diabetes

Country Status (9)

Country Link
EP (1) EP0303308B1 (ja)
JP (1) JPS6466129A (ja)
KR (1) KR890003403A (ja)
AT (1) ATE63821T1 (ja)
AU (1) AU612169B2 (ja)
DE (1) DE3863027D1 (ja)
DK (1) DK418788A (ja)
NZ (1) NZ225621A (ja)
ZA (1) ZA885502B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
WO1993015752A1 (en) * 1992-02-17 1993-08-19 Akzo N.V. Anti-neuropathic composition
WO1993023072A1 (en) * 1992-05-13 1993-11-25 Akzo N.V. Aqueous hexapeptide compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
CH650679A5 (de) * 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
CA1196863A (en) * 1983-06-08 1985-11-19 Mattheus F.A. Goosen Slow release injectable insulin composition
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system

Also Published As

Publication number Publication date
ATE63821T1 (de) 1991-06-15
KR890003403A (ko) 1989-04-14
DK418788A (da) 1989-02-15
DE3863027D1 (de) 1991-07-04
DK418788D0 (da) 1988-07-26
EP0303308B1 (en) 1991-05-29
AU612169B2 (en) 1991-07-04
ZA885502B (en) 1989-04-26
NZ225621A (en) 1990-11-27
EP0303308A1 (en) 1989-02-15
AU2063388A (en) 1989-02-16

Similar Documents

Publication Publication Date Title
US4826810A (en) System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof
Rosskamp et al. Long-acting insulin analogs
EP0495531B1 (en) Apparatus for the endermic application of medicines
Blackshear Implantable drug-delivery systems
US6786244B1 (en) Apparatus and method to enhance reservoir utilization in a medical infusion device
AU620536B2 (en) Appliance for injection of liquid formulations
Irsigler et al. Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin infusion device
Goberna et al. Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas
HUT47575A (en) Process for production of piperasinal derivatives of purine and medical compositions containing them
KR20090059146A (ko) 미세펌프 작동식 약물 투여 장치
Konturek et al. Effect of diversion and replacement of bile on pancreatic secretion
AU5930990A (en) Syringe for injecting metered quantities of various liquid therapeutic agents
JPS6466129A (en) Medicine for preventing and treating complication of diabetes
Danguir Food intake in rats is increased by intracerebroventricular infusion of the somatostatin analogue SMS 201–995 and is decreased by somatostatin antiserum
CA1283206C (en) Insulin delivery algorithm
Yamaguchi et al. Calcitonin Gene—Related Peptide and Induction of Hyperglycemia in Conscious Rats In Vivo
LERNER The augmentation effect of secretin on the insulin responses to known stimuli: specificity for glucose
DE69332055T2 (de) Zusammensetzung von Argatroban zur Verwendung in Ophthalmologie
CA2480572A1 (en) Device for infusing insulin
JPH0568267B2 (ja)
KANETO et al. Stimulation of glucagon secretion by arginine and histidine infused intrapancreatically
SU1527654A1 (ru) Способ моделировани сахарного диабета
SU1500289A1 (ru) Способ лечени повреждений и воспалительных поражений переднего отдела глаза у больных сахарным диабетом
JPS6461420A (en) Alpha-ethiocholanedione drug, and method of causing high hematic concentration alpha-ethiocholanone
Dillon Role of cholinergic nervous system in healing neuropathic lesions: preliminary studies and prospective, double-blinded, placebo-controlled studies